Mersana Therapeutics Inc Cash Flow Reinvestment Rate

Latest as of September 2022: 0.30x

Mersana Therapeutics Inc cash flow reinvestment rate. Mersana Therapeutics Inc (MRSN) has a Cash Flow Reinvestment Rate of 0.30x as of September 2022, reinvesting $16.49 Million (capex $426.00K plus investments $-16.07 Million) from operating cash flow of $54.60 Million. Explore Mersana Therapeutics Inc debt service capacity to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.30x

(Capex + Investments) / Operating CF

Total Reinvested

$16.49 Million

Capex + Investments

Operating Cash Flow

$54.60 Million

USD

Capital Expenditures

$426.00K

USD

Cash Flow Reinvestment Rate of Mersana Therapeutics Inc (2016–2016)

Cash flow reinvestment rate of Mersana Therapeutics Inc from 2016 to 2016. Historical reinvestment intensity for Mersana Therapeutics Inc across 1 annual periods. Explore MRSN capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.

Mersana Therapeutics Inc Cash Flow Reinvestment Rate by Year (2016–2016)

Mersana Therapeutics Inc cash flow reinvestment rate by year from 2016 to 2016. Year-by-year capital reinvestment analysis for Mersana Therapeutics Inc. For the full cash flow conversion analysis, see Mersana Therapeutics Inc cash conversion from operations.

Year	Reinvestment Rate	Total Reinvested (USD)	Operating CF	Capex	YoY Change
2016	0.07x	$2.17 Million	$31.59 Million	$1.08 Million	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow